BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 15473315)

  • 41. Passage in Vero cells alters the characteristics of measles AIK-C vaccine strain.
    Uejima H; Nakayama T; Komase K
    Vaccine; 2006 Feb; 24(7):931-6. PubMed ID: 16176848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suspension-Vero cell cultures as a platform for viral vaccine production.
    Paillet C; Forno G; Kratje R; Etcheverrigaray M
    Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Qualification of working cell banks for the Vero cell line to produce licensed human vaccines.
    Vincent-Falquet JC; Peyron L; Souvras M; Moulin JC; Tektoff J; Patet J
    Dev Biol Stand; 1989; 70():153-6. PubMed ID: 2759347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The karyotypic variability of mouse embryonic fibroblasts of 2 genotypes during spontaneous neoplastic transformation].
    Glazko TT; Lavrovskiĭ VA
    Tsitologiia; 1990; 32(2):171-80. PubMed ID: 2368161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Establishment and characterization of a human T-cell leukemia line (LALW-2) in nude mice.
    White L; Meyer PR; Benedict WF
    J Natl Cancer Inst; 1984 May; 72(5):1029-38. PubMed ID: 6609263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccine.
    Tatalick LM; Gerard CJ; Takeya R; Price DN; Thorne BA; Wyatt LM; Anklesaria P
    Vaccine; 2005 Apr; 23(20):2628-38. PubMed ID: 15780446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On the karyotypic origin and evolution of cancer cells.
    Nicholson JM; Duesberg P
    Cancer Genet Cytogenet; 2009 Oct; 194(2):96-110. PubMed ID: 19781442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of S100P protein correlates with and contributes to the tumorigenic capacity of HeLa cervical carcinoma cells.
    Gibadulinová A; Baráthová M; Kopácek J; Hulíková A; Pastoreková S; Kettmann R; Pastorek J
    Oncol Rep; 2005 Aug; 14(2):575-82. PubMed ID: 16012747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experience with vero cells at Pasteur Mérieux Connaught.
    Montagnon BJ; Vincent-Falquet JC; Saluzzo JF
    Dev Biol Stand; 1999; 98():137-40; discussion 167. PubMed ID: 10494966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oncolytic recombinant herpes simplex virus for treatment of orthotopic liver tumors in nude mice.
    Chung YS; Miyatake S; Miyamoto A; Miyamoto Y; Dohi T; Tanigawa N
    Int J Oncol; 2006 Apr; 28(4):793-8. PubMed ID: 16525626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Establishment and characterization of a tumorigenic trophoblast-like cell line from a human placenta.
    Ho CK; Chiang H; Li SY; Yuan CC; Ng HT
    Cancer Res; 1987 Jun; 47(12):3220-4. PubMed ID: 3581066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stability of canine distemper virus (CDV) after 20 passages in Vero-DST cells expressing the receptor protein for CDV.
    Lan NT; Yamaguchi R; Kawabata A; Uchida K; Kai K; Sugano S; Tateyama S
    Vet Microbiol; 2006 Dec; 118(3-4):177-88. PubMed ID: 16982161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of the infectivity of dengue 1 strains in the HepG2 and Vero cell lines].
    Aguilar Barroso A; Amin Blanco N; Morier Díaz L; Pérez Hernández EM
    Rev Cubana Med Trop; 2005; 57(2):105-10. PubMed ID: 17966579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biologic characterization of canine melanoma cell lines.
    Wolfe LG; Oliver JL; Smith BB; Toivio-Kinnucan MA; Powers RD; Brawner WR; Henderson RA; Hankes GH
    Am J Vet Res; 1987 Nov; 48(11):1642-8. PubMed ID: 3434911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
    Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
    Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of cytotoxic activity of Vibrio cholerae non-01 culture filtrate on established cell lines and human diploid cells].
    Pancer K; Stypułkowska-Misiurewicz H; Jarzabek Z
    Med Dosw Mikrobiol; 2000; 52(2):139-50. PubMed ID: 11107788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal karyotype and genetic signature analysis of cultured human colon adenocarcinoma cell lines LS180 and LS174T.
    Rutzky LP; Kaye CI; Siciliano MJ; Chao M; Kahan BD
    Cancer Res; 1980 May; 40(5):1443-8. PubMed ID: 7370982
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation and comparative studies of inactivated rabies vaccines obtained in the heterologous diploid and polyploid cells (HAK, BHK and VERO).
    Atanasiu P; Perrin P; Segre L; Manganas O
    Dev Biol Stand; 1981; 50():173-82. PubMed ID: 7341292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
    Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
    Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.
    Monath TP; Myers GA; Beck RA; Knauber M; Scappaticci K; Pullano T; Archambault WT; Catalan J; Miller C; Zhang ZX; Shin S; Pugachev K; Draper K; Levenbook IS; Guirakhoo F
    Biologicals; 2005 Sep; 33(3):131-44. PubMed ID: 15975826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.